INSIGHTEC has invented a new non-invasive surgery technology based on MRI-guided focused ultrasound. The financing round may reach $150 million
Koch, Inc. leads a $150 million funding round in the medical devices company INSIGHTEC from Haifa, Israel. During the fist stage of the round, Kock will bring its own $75 million for approximately 17% of the company. Other investors plan to join Koch with an extra funding of up to $75 million. The deal was made under company evaluation $460 million. INSIGHTEC has invented a new non-invasive surgery technology based on MRI-guided focused ultrasound. The company’s non-invasive therapy platforms, Exablate and Exablate Neuro, are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and uterine fibroids.
